Prosthetics:optune plus transducers 3 month supply
Ended Awarded Last action
- Contract number
- 36C26226F0238
- Awardee
-
Novocure Inc. UEI P3S3GK3DTUA8
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $49,749
Award facts
- Contract value 100% obligated
- $49,748.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Portsmouth, NH 03801, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 22, awarded a delivery order valued at $49,748.73 to Novocure Inc. on April 23, 2026, for a three-month supply of Optune Plus transducers, medical devices used in cancer treatment. The award is structured as a firm fixed-price delivery order with no set-aside designation and will be performed at the VA medical facility in Portsmouth, New Hampshire, with an ultimate completion date of June 26, 2026. This delivery order is issued under Novocure's existing General Services Administration Federal Supply Schedule contract (FSS-65-II-A) for Medical Equipment and Supplies, a $28.85 million multiple-award contract established on November 1, 2022, and extending through October 31, 2027.
Novocure Inc., a foreign-owned medical device manufacturer specializing in innovative cancer treatment technologies, serves as the prime contractor with no subcontractor involvement, ensuring direct control over its proprietary Tumor Treating Fields technology. The company has established itself as the primary sole-source provider of Optune devices to the Veterans Health Administration, with over 100 delivery orders and purchase orders issued across Veterans Integrated Service Networks nationwide since the FSS contract's inception. These products expand veterans' access to non-invasive therapeutic options for solid tumor cancers, including FDA-approved applications for glioblastoma and mesothelioma, delivering critical cancer treatment capabilities to VA medical facilities throughout the system.
Quick answers
Who was awarded contract 36C26226F0238?
36C26226F0238 was awarded to Novocure Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on April 23, 2026.
How much is contract 36C26226F0238 worth?
The government has obligated $49,749 on 36C26226F0238.
Is contract 36C26226F0238 an order under another contract?
Yes. 36C26226F0238 is a delivery order under 36F79723D0016, a federal supply schedule, on Medical Equipment and Supplies (FSS-65-II-A).
Was contract 36C26226F0238 competed?
The extent of competition for 36C26226F0238 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award